All Compounds
Plain-language profiles for the compounds we cover, with practical summaries, delivery context, and links into the deeper editorial coverage.
33 compounds
BPC-157
The biggest recovery peptide by public search interest, with strong curiosity and limited human-standardized evidence.
View compound →
PT-141
The clearest compound anchor in the sexual-wellness lane, with strong demand around delivery, timing, and experience questions.
View compound →
GHK-Cu
The best-known copper peptide in appearance coverage, with strong hair, skin, and repair crossover interest.
View compound →
Ipamorelin
A selective GH secretagogue with durable stack demand, especially next to CJC-1295.
View compound →
Semaglutide
The most studied weight-loss peptide, with the deepest safety record and the broadest formulation range.
View compound →
Pinealon
A neurocognitive peptide with circadian and longevity crossover interest, still firmly in the experimental lane.
View compound →
Sermorelin
A classic GH-secretagogue starter compound that anchors a large share of the performance peptide conversation.
View compound →
TB-500
A recovery-focused compound that overlaps with BPC-157 in search demand and stack-oriented use questions.
View compound →
Tesamorelin
A well-documented GHRH analog with one of the clearest visceral-fat angles in the broader peptide discussion.
View compound →
Tirzepatide
A dual-action incretin compound with some of the strongest average weight-loss data in current use.
View compound →
AHK-Cu
A hair-focused copper peptide that expands the site's coverage beyond GHK-Cu without leaving the same editorial lane.
View compound →
AOD-9604
A GH-fragment weight-loss compound that keeps showing up in fat-loss research and protocol-driven search demand.
View compound →
